← All trials
NCT06976437
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 6, 2025
- Primary completion
- May 20, 2027
- Completion date
- Dec 30, 2027
- First posted
- May 16, 2025
- Last posted
- Jul 10, 2025
- Enrollment
- 21
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jiangsu UniversityLead sponsor
- Rui Therapeutics Co., LtdCollaborator
- Jiangsu UniversitySponsor investigator
- Allorunning TherapeuticsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.